roduct Description
Product Name: Ledipasvir & Sofosbuvir Tablets
Composition: Ledipasvir 90 mg + Sofosbuvir 400 mg
Form: Oral Tablet
Category: Antiviral / Direct-Acting Antiviral (DAA)
Indication: Chronic Hepatitis C Virus (HCV) Infection – Genotype 1, 4, 5, and 6
Ledipasvir & Sofosbuvir Tablets is a fixed-dose combination antiviral medication used for the treatment of chronic hepatitis C virus (HCV) infection, primarily genotypes 1, 4, 5, and 6. This combination offers a highly effective once-daily oral therapy that directly targets and disrupts viral replication processes, helping to achieve a sustained virologic response (SVR) — considered a cure.
